Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Real Time PCR
DNA/RNA Purification
Segmented by End User/Segment
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Roche Diagnostics
Fluxergy
Cepheid
Atlas Genetics
Abbott Laboratories
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status and Forecast (2016-2027) 1.3.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Supply by Company 2.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value by Company 2.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status by Category 3.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Category Introduction 3.1.1 Real Time PCR 3.1.2 DNA/RNA Purification 3.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status by End User/Segment 4.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Segment by End User/Segment 4.1.1 Hospitals 4.1.2 Ambulatory Surgical Centers 4.1.3 Diagnostic Centers 4.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status by Region 5.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Region 5.2 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 5.3 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 5.4 Asia Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 5.5 Central & South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 5.6 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status6 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 7.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 8.1 Asia Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 9.1 Central & South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Status 10.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Category and by End User/Segment 12.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value Forecast (2022-2027) 12.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecast by Category 12.3 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Forecast by End User/Segment13 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Region/Country 13.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Roche Diagnostics 14.1.1 Company Information 14.1.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Introduction 14.1.3 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Fluxergy 14.2.1 Company Information 14.2.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Introduction 14.2.3 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Cepheid 14.3.1 Company Information 14.3.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Introduction 14.3.3 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Atlas Genetics 14.4.1 Company Information 14.4.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Introduction 14.4.3 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Abbott Laboratories 14.5.1 Company Information 14.5.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product Introduction 14.5.3 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis ...15 Conclusion16 Methodology